Trademark Overview
On Friday, February 20, 2026, a trademark application was filed for AQUACYS with the United States Patent and Trademark Office. The USPTO has given the AQUACYS trademark a serial number of 99663191. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, February 20, 2026. This trademark is owned by Aarvik Therapeutics, Inc.. The AQUACYS trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Antibody technology platform incorporating engineered cysteines for use in conjugating cysteine reactive small and large molecules, for medical diagnosis and treatment purposes; Antibody technology platform incorporating engineered cysteines for use in conjugating cysteine reactive small and large molecules, resulting in conjugates with improved hydrophilicity, for medical diagnosis and treatment purposes; Antibody technology platform used to incorporate cysteines into an antibody, namely protein arrays, for medical diagnosis and treatment purposes; Delivery devices for antibodies, namely, drug delivery agents in the form of antibody conjugates that facilitate the delivery and action of medical preparations; Antibody products, namely, antibody conjugates for medical diagnosis and treatment in the fields of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders; Chemical, biological and biochemical products for medical and pharmaceutical use, namely, anti...
Research and development of antibody conjugates; Scientific research for medical purposes in the field of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders; Research and development services in the field of antibodies; Scientific and technological services and research relating thereto, namely, scientific research, analysis and testing in the fields of antibody conjugates; Antibody engineering; Custom design and engineering of antibodies; Research and development of pharmaceuticals for the treatment of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Research, development and establishment of testing specifications and procedures in the fields of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders research, diagnosis and treatment; Providing scientific research info...
Antibodies and antibody conjugates for scientific purposes, other than for medical or veterinary purposes; Antibody conjugates for use in the formation of nanoparticles, for scientific and medical research; Chemical substances for the formation of antibody conjugates for use in scientific and medical research; Diagnostic products for scientific and medical research use in the field of antibody conjugates for scientific and medical research; Antibody conjugate technology platform used to incorporate cysteines into an antibody, namely, protein arrays and nucleotide arrays for scientific and medical research; Antibody technology platform incorporating engineered cysteines for use in conjugating cysteine reactive small and large molecules, resulting in conjugates with improved hydrophilicity, for scientific and medical research; Antibody technology platform incorporating engineered cysteines for use in conjugating cysteine reactive small and large molecules, for scientific and medical rese...
